Condition
HIP AND KNEE OSTEOARTHRITIS
Total Trials
5
Recruiting
1
Active
1
Completed
3
Success Rate
75.0%-12% vs avg
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
Termination Rate
20.0%
1 terminated out of 5 trials
Success Rate
75.0%
-11.5% vs benchmark
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
75% success
Data Visualizations
Phase Distribution
1Total
P 3 (1)
Trial Status
Completed3
Terminated1
Recruiting1
Trial Success Rate
75.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07304323RecruitingPrimary
Prepare II - Predictive Model Training and External Validation
NCT06717724Phase 3CompletedPrimary
§ Procaine Periarticular Injections for Pain Reduction in Elderly With Osteoarthritis
NCT02137655CompletedPrimary
Recovery After Fast Track THA / TKA
NCT01601951CompletedPrimary
Outcomes Data of Bone Marrow Stem Cells to Treat Hip and Knee Osteoarthritis
NCT00522080TerminatedPrimary
Screening for Hip and Knee Osteoarthritis in the General Population: Predictive Value of a Questionnaire and Prevalence Estimates
Showing all 5 trials